Stockreport

Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]

Werewolf Therapeutics, Inc.  (HOWL) 
PDF This compares to loss of $0.39 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 23.26 [Read more]